Benzovindiflupyr has gained increasing
attention as a new chiral succinate dehydrogenase inhibitor fungicide;
however, its determination, bioactivity, and mechanism at the enantiomeric
level are very limited. In the present study, optical rotation determination
and X-ray single-crystal diffraction results identified that the absolute
configurations were (+)-(1R,4S)-benzovindiflupyr
and (−)-(1S,4R)-benzovindiflupyr.
A quantitative determination method for enantiomers was established
using high-performance liquid chromatography tandem mass spectrometry
(HPLC–MS/MS) for pesticide detection. The stereoselective bioactivity
assay indicated that (−)-(1S,4R)-benzovindiflupyr exhibited greater potency than (+)-(1R,4S)-benzovindiflupyr against seven phytopathogenic
fungi. Molecular docking analysis showed that (−)-(1S,4R)-benzovindiflupyr possessed a stronger
binding affinity to succinate dehydrogenase than (+)-(1R,4S)-benzovindiflupyr. The binding modes between
enantiomers and the mutant with H272(B) predicted that the phytopathogenic
fungi with H272(B) of succinate dehydrogenase mutation would not be
resistant to benzovindiflupyr enantiomers. This study provides a basis
for residue evaluation, risk assessment, and the safe application
of benzovindiflupyr at the enantiomer level.